Article

Dispute Develops Over Discount Drug Program

When a private oncology practice in Memphis formed a partnership with a nearby hospital in late 2011, the organizations proclaimed that the deal would “transform cancer care” in the region.

What they did not emphasize was that the deal would also create a windfall for them worth millions of dollars a year, courtesy of an obscure federally mandated drug discount program.

Read the full story: http://nyti.ms/151Xwmq

Source: The New York Times

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Amir Fathi, MD, Massachusetts General Hospital
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo